First National Daily eMedical Newspaper of India
Nobody Reports News Better Than Us  
Editorial (Dr K K Aggarwal)                                                                                                   (Dr RN Tandon)
To Read the full story on emedinexus.com, or download our Android app or iOS app
7th January 2017
IMA Views on Capping of Stent Prices
  •  IMA is concerned about the public perception that there is a nexus between the doctors and the hospitals/ companies manufacturing stents and that all doctors take commissions for every stent put in the patients. This perception needs to be removed at any level.
  • IMA supports bringing stents under the National List of Essential Medicines and welcomes the Govt. steps in capping their price.
  • It is also true that every year newer stents are introduced in the market, which invariably may be priced at higher at rates, but IMA is of the consistent view that costlier does not mean better and a product that has been the best in 2016 cannot be outdated in 2017.
  • IMA’s stand is that, all models of stents available in the market till December 2016 be capped at a fixed price.  For new models introduced in 2017, a special committee may take a decision on the merits depending upon evidence-based reports showing how they are better than the older generation stents in reducing morbidity and mortality.
(Contributions from Dr RN Tandon)
 
Dr KK Aggarwal
National President IMA and HCFI
To Read More or Comment, Click Here
Top News
Practice Updates
eMedi Humor
Medicolegal Corner
eMedi Quiz

a.    Agglutination testing of maternal serum
b.    Enzyme-linked immunosorbent assay (ELISA) screening of maternal serum
c.    Western blot testing of maternal serum
d.    Reverse transcription-polymerase chain reaction (RT-PCR) testing of maternal serum
Lifestyle Updates
 
Inspirational Story 2Don't Sweat the Small Stuff 
Press Release
Measles-Rubella initiative: IMA urges support in favor of the campaign

About 139 million children in India under the age of 9 months to 10 years are susceptible to Measles and Rubella infection. The medical community needs to support the campaign and accelerate its progress.

New Delhi, Jan 06, 2017: India, along with other WHO-SEAR countries, in September 2013, resolved to eliminate measles and control rubella/congenital rubella syndrome by 2020. Accordingly, Ministry of Health & Family Welfare has introduced Rubella vaccine in its Universal Immunization Programmed as Measles-Rubella vaccine. 
 
The MR (Measles-Rubella) vaccination campaign is scheduled from February 7 to February 24 and will cover the city schools in its first week. Karnataka, Tamil Nadu, Goa, Puducherry and Lakshadweep are places where the vaccine will be introduced.
To Read More or Comment, Click Here
Pedicon 2017
IMA Updates